F-Prime Capital - Unicorn Nest

F-Prime Capital

F-Prime Capital

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, Cambridge

About

F-Prime Capital is the renowned VC, which was created in 1946. The VC's location is in North America, United States. The main office of this VC is situated in Cambridge.

We also identified another 11 core personnel in our database.

F-Prime Capital participates, on average, in 11 percentage points less than the average amount of lead investments in other funds. Typical investments for this fund are deals in the range of 10 - 50 millions dollars. The fund usually participates in 13-24 investment rounds per year. The most exits for the fund occurred in 2018. The fund's activity peaked in 2018. In addition, the fund was active in 2019. At the time of investment by F-Prime Capital, a typical start-up valuation would be 500 millions - 1 billion dollars. In real terms, this VC performs 5 percentage points more exits than other funds.

Among their most successful investment fields, we have identified Health Care, Pharmaceutical. Also, because of its portfolio diversification tendency, we can highlight 24 more industries for this fund. Moreover, a start-up needs to be 4-5 years old to get investment from this fund. The fund has no a preferred number of founders for start-ups that it invests in. When a start-up has 5+ founders, the probability of closing the deal is low. The country of its foundation and the country of the most frequent investments for the fund coincides - United States. In addition to this location, the fund participated in 4 other locations. Among the most popular portfolio start-ups of the fund, are Innovent Biologics, Devoted Health, Denali Therapeutics.

The usual method for the fund is to invest in rounds with 5-6 other investors. Aside from F-Prime Capital, start-ups are often funded by Y Combinator, Venrock, Maverick Ventures and 105 other funds. The most common co-investors for the fund are ARCH Venture Partners, Sofinnova Investments, Oak HC/FT and also 135 different VCs. In subsequent rounds, the fund is usually supported by Venrock, Cormorant Asset Management, Temasek Holdings, out of 97 investors from our database.

Year Founded

1946

Fund Activity

Operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: fprimecapital.com; User name format in descending order of probability: first_initial last, first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Investments per Year [average amount of rounds in which fund participates each year]

1-3

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

28.4% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x6

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

2.6 years

Decision Makers / Strategy
Similarity Index [see explanation at unicorn-nest.com/dataset-what-we-tweet-vs-what-we-invest]

0.2 out of 1

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.7 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]

7

Funds Investing in Previous
Rounds

Y Combinator, Venrock, Maverick Ventures

Funds Investing in Following
Rounds

Venrock, Cormorant Asset Management, Temasek Holdings

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: